
IndraLab
Statements
Tofacitinib inhibits RELA. 3 / 3
|
3
reach
"Mechanistically, we demonstrate that tofacitinib suppresses ox-LDL-mediated activation of NF-kappaB inhibitor alpha (IkappaB-alpha), accumulation of nuclear p65 and activation of nuclear factor kappaB (NF-kappaB) promoter, indicating that tofacitinib inhibits NF-kappaB activation."